BrainStorm Cell Therapeutics appoints new Chief Operating Officer and Chief Medical Officer Genetics Investing
NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016 Genetics Investing
Cancer Genetics, Inc. to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program Genetics Investing
ToolGen Highlights Study Results Demonstrating Utility of AAV-Compatible Cas9 System in vivo Genome Editing Genetics Investing
Myriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, Olaparib Genetics Investing
Alder BioPharmaceuticals to Host Conference Call to Discuss Fourth Quarter and Full Year 2016 Financial and Operating Results Biotech Investing
Cancer Genetics' Hereditary Breast & Ovarian Cancer Panel Selected by Global Biopharma to Power 1,000+ Patient Clinical Study Genetics Investing